Pfizer Wins Appeal Against UK Fine for Epilepsy Drug Price Hike Pfizer Wins Appeal Against UK Fine for Epilepsy Drug Price Hike

Pfizer Inc and Flynn Pharma won an appeal on Thursday against fines totalling nearly 90 million pounds ($120 million) imposed in 2016 for ramping up the cost of an epilepsy drug.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news